Thievon-Wright Consulting Group has been involved in the conduct of over 1,000 clinical trials in Central Nervous System disorders and clinical pharmacology. We draw upon this unique level of expertise as we consult with pharmaceutical, biotechnology and CRO industries on protocol and program designs. We clearly understand the complexities of the drug development process and strive to balance the needs of our clients with the most reasonable, efficient and economic solutions.
Key Opinion Leaders
Within our network of clinical research organizations, we have direct access to a variety of Key Opinion Leaders (KOLs). Areas of particular research expertise include Schizophrenia and Psychotic Disorders, Anxiety and Depressive Disorders, Alzheimer’s Disease, Sleep Disorders, Pain, Addiction and Abuse Liability. We put our pharmaceutical, biotechnology and CRO clients in direct contact with these KOLs.
A key element of any clinical trial program is the study budget. Our finance team has developed an efficient and accurate method for budgeting even the most challenging of clinical trials based on historical data. As pharmaceutical, biotechnology and Contract Research Organization (CRO) clients plan out their budgets and proposals, Thievon-Wright Consulting group can provide specific budget information to aid in their planning. This service is typically complimentary.